Phase II study of first-line LY231514 (multi-targeted antifolate) in patients with locally advanced or metastatic colorectal cancer: an NCIC Clinical Trials Group study.

C Cripps; M Burnell; J Jolivet; G Batist; W Lofters; J Dancey; J Iglesias; B Fisher; E A Eisenhauer

doi:10.1023/a:1008372529239

Phase II study of first-line LY231514 (multi-targeted antifolate) in patients with locally advanced or metastatic colorectal cancer: an NCIC Clinical Trials Group study.

Identifier:nobleid.org/w1/20260515/AC2C2A07

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/AC2C2A07.svg?ark=w1%2F20260515%2FAC2C2A07)](https://nobleid.org/work/w1/20260515/AC2C2A07)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Phase II study of first-line LY231514 (multi-targeted antifolate) in patients with locally advanced or metastatic colorectal cancer: an NCIC Clinical Trials Group study.

Identifier:nobleid.org/w1/20260515/AC2C2A07

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/AC2C2A07.svg?ark=w1%2F20260515%2FAC2C2A07)](https://nobleid.org/work/w1/20260515/AC2C2A07)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work